B

BrightSpec, Inc.

20 employees

Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.

Basic info

Industry

biotechnology research

Sectors

Metabolomics
medical
molecular rotational resonance
cbd
science and environment
Impurity Analysis
Isomers
GC-MRR
Gas mixture analysis
synthetic chemistry
environmental testing
Isomer
Analytics
LC-MS
spectroscopy
Process monitoring
Deuterated Drugs
structure elucidation
medicinal chemistry
chemical analysis
PAT
Protein Degredation
Chemical Engineering
Pharmaceutical impurity analysis
natural products
GC-MS
bio-manufacturing
Chiral analysis
environmental analysis
Bench-top analytical chemistry
continuous manufacturing
process monitoring
chiral
flow chemistry
gas chromatography
Test and Measurement

Date founded

2012

Funding rounds raised

Total raised

$18M

from 6 investors over 6 rounds

B

BrightSpec, Inc. raised $18M on December 14, 2022

Investors: Medvest Capital, University of Virginia Patent Foundation, Felton Group LLC and Genoa Ventures

B

BrightSpec, Inc. raised undisclosed on August 1, 2020

Investors: University of Virginia Patent Foundation and CAV Angels

FAQ